SCHEMBL22097170

SCHEMBL22097170

c1ccc(-c2nc(-c3ccc4c(c3)c3ccccc3c3ccc5oc6ccc7ccccc7c6c5c34)nc3ccccc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ATM Q13315 1/20 0.48
ABCG2 Q9UNQ0 4/20 0.40
PAX8 Q06710 2/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
FYN P06241 1/20 0.40
MAPK3 P27361 1/20 0.40
AHR P35869 1/20 0.40
WHR1 P49842 1/20 0.40
MAPT P10636 4/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NUDT1 P36639 3/20 0.38
ADORA2A P29274 2/20 0.38
HPGD P15428 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22096957 0.92 MAPT (0.40) MEN1KMT2AATMABCG2PAX8
SCHEMBL22096984 0.90 MEN1 (0.50) MEN1KMT2AATMWHR1MAPT
SCHEMBL20228694 0.90 MEN1 (0.55) MEN1KMT2AATMCYP1A2AHR
SCHEMBL24628038 0.88 MEN1 (0.52) MEN1KMT2AATMABCG2CYP1A2
SCHEMBL22097102 0.87 ABCG2 (0.46) KMT2AABCG2PAX8CYP1A1CYP1A2
SCHEMBL22260179 0.87 ABCG2 (0.46) KMT2AABCG2PAX8CYP1A1CYP1A2
SCHEMBL22097022 0.87 TDP1 (0.39) MEN1KMT2AATMABCG2PAX8
SCHEMBL24628218 0.86 MEN1 (0.51) MEN1KMT2AATMABCG2CYP1A2
SCHEMBL24473232 0.86 MEN1 (0.54) MEN1KMT2AATMCYP1A2FYN
SCHEMBL24472889 0.86 MEN1 (0.59) MEN1KMT2AATMWHR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 MEN1 1207/4885KMT2A 2500/4885ATM 3884/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 MEN1 1207/4885KMT2A 2500/4885ATM 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.